Claim Missing Document
Check
Articles

Found 2 Documents
Search

STUDY OF PRESCRIPTION PROFILE OF PATIENTS WITH BRONCHIAL ASTHMA AT PARSOBURAN COMMUNITY HEALTH CITY PEMATANGSIANTAR PERIOD JANUARY-MARCH 2017 I Ngurah Gede Verar Fujastawan; Bernido Raflo Purba; Marthalena Erbin Nahak; Dilla Sastia Mara; Muharti Sanjaya
International Conference on Health Science, Green Economics, Educational Review and Technology Vol. 3 (2021): International Conference on Health Science, Green Economics, Educational Review and T
Publisher : Universitas Efarina

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54443/ihert.v3i.243

Abstract

Bronchial asthma has varying incidence rates in different countries, but there is a tendency for this disease to increase in number, even though asthma medications have been developed. This study aims to determine the pattern of treatment of bronchial asthma in patients at the Parsoburan Health Center, Pematangsiantar City for the period January-March 2017. This research was a non-experimental (observational) descriptive study conducted using a retrospective method. The data used are medical records of bronchial asthma patients. The results of the study showed that in the January-March 2017 period there were 18 cases of bronchial asthma. The gender distribution of bronchial asthma patients was 66.7% male and 33.3% female, while the age distribution of bronchial asthma patients was divided into 4 groups, namely, Toddlers (0≤5 years) by 33.3%, children (5<n<12 years) by 5.6%, adults (12<n<65 years) by 38.9%, and elderly (> 65 years) of 22.2% The general description of prescribing the highest number of drugs given to bronchial asthma patients in one prescription are 5 and 6 drugs each of 38.9%, the distribution of drug classes used for therapy includes, bronchodilators 25, 7%, mucolytic 18.5%, corticosteroid 15.5%, anti-microbial 15.5%, anti-hypoxemia 4.1%, analgesic 6.2%, anti-histamine 3.1% and accompanying drugs (anti- diabetic, anti-epileptic, anti-hypertensive, anti-angina, and vitamins) given at 1% each. Distribution of discrepancies in drug administration based on the Indonesian National Drug Informatorium standard of 17.5%, based on the Physicians Drug Handbook standard of 0%,
RATIONALITY OF THE USE OF NSAIDS IN rheumatic OSTEOARTHRITIS PATIENTS AT THE PUSKESMAS SINGOSARI, PEMATANGSIANTA CITY, JANUARY FEBRUARY 2019 PERIOD I Ngurah Gede Verar Fujastawan; Mustaruddin; Beta Hanindiya; Dian Permata Nasution; Ismi Noer Fadilah; Hendri Kurniawan; Marthalea Erbin Nahak; Bernido Raflo Purba
International Conference on Health Science, Green Economics, Educational Review and Technology Vol. 4 (2022): International Conference on Health Science, Green Economics, Educational Review and T
Publisher : Universitas Efarina

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54443/ihert.v4i.245

Abstract

Osteoarthritis (OA) is the most common form of arthritis found in the community, is chronic in nature, has a major impact on public health issues. a total of 213 arthritis patients, only 30 patients who met the inclusion criteria were due to incomplete medical record data or even loss of medical record data which caused the patient's medical record data to be incomplete. As for the aspect of rationality in terms of 6 accuracy (right diagnosis, right indication, right drug, right dose, right route of administration, right patient) then the results of the analysis show that accuracy is 100% right, while for the exact parameters of the drug is still worth 53%. So it can be concluded that treatment for osteoarthritis patients when viewed from the right diagnosis, right indication, right dose, right patient, right drug, right method of administration at the Singosari Health Center cannot be fully rational.